Cytokeratin 20 as an objective marker of urothelial dysplasia

British Journal of Urology

Volumn 78, Issue 6, 1996, Pages 870-875

  Harnden, P ^a   Eardley, I ^a,b   Joyce, A D ^a,b   Southgate, J ^a,b  

^a LEEDS GENERAL INFIRMARY   (United Kingdom)

^b ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

Carcinoma in situ; Cytokeratin 20; Dysplasia; Urinary bladder; Urothelium

Indexed keywords

CYTOKERATIN;

ARTICLE; BLADDER BIOPSY; BLADDER CARCINOMA; CANCER DIAGNOSIS; CARCINOMA IN SITU; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DYSPLASIA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; TRANSITIONAL CELL CARCINOMA; UROTHELIUM;

EID: 0030430161     PISSN: 00071331     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-410x.1996.23511.x     Document Type: Article

References (26)

1. Melicow MM. Histological study of vesical urothelium intervening between gross neoplasms in total cystectomy. J Urol 1952; 68: 261-79
2. Melicow MM, Hollowell JW. Intraurothelial cancer: carcinoma in situ, Bowen's disease of the urinary system: discussion of thirty cases. ; Urol 1952: 68: 763-72
3. Richards B. Parmar MK, Anderson CK et al. Interpretation of biopsies of 'normal' urothelium in patients with superficial bladder cancer. MRC Superficial Bladder Cancer Sub Group. Br J Urol 1991; 67: 369-75
4. Wolf H, Hojgaard K. Prognostic factors in local surgical treatment of invasive bladder cancer, with special reference to the presence of urothelial dysplasia. Cancer 1983: 51: 1710-5
5. Pagano F. Garbeglio A, Milan! C, Bassi P, Pegoraro V. Prognosis of bladder cancer. I. Risk factors in superficial transitional cell carcinoma. Eur Urol 1987; 13: 145-9
6. Mufti GR. Singh M. Value of random mucosal biopsies in the management of superficial bladder cancer. Eur Urol 1992; 22: 288-93
7. Ozen H, Remzi D. Akdas A, Ruacan S. Biopsy of apparently normal bladder mucosa in patients with bladder carcinoma and its prognostic importance. Int Urol Neph 1983; 15: 327-32
8. Heney NM. Ahmed S, Flanagan MJ et al. Superficial bladder cancer: progression and recurrence. J Urol 1983; 130: 1083-6
9. Wolf H. Hojgaard K. Urothelial dysplasia concomitant with bladder tumours as a determinant factor for future new occurrences. Lancet 1983; 2: 134-6
10. Wolf H. Olsen PR. Hojgaard K. Urothelial dysplasia concomitant with bladder tumours: a determinant for future new occurrences in patients treated by full-course radiotherapy. Lancet 1985; 1: 1005-8
11. Vicente J, Laguna MP. Duarte D, Algaba F, Chechile G. Carcinoma in situ as a prognostic factor for G3pTl bladder tumours. Br J Urol 1991; 68: 380-2
12. Kiemeney LA. Witjes JA, Heijbroek RP. Debruyne FM, Verbeek AL. Dysplasia in normal-looking urothelium increases the risk of tumour progression in primary superficial bladder cancer. Eur J Cancer 1994; 30A: 1621-5
13. Hare wood LM. The significance of urothelial dysplasia as diagnosed by cup biopsies. Aust N Z J Surg 1986; 56:199-203
14. Robcrtson AJ, Beck JS, Burnett R A et al. Observer variability in histopathological reporting of transitional cell carcinoma and epithelial dysplasia in bladders. J Clin Pathol 1990:45: 17-21
15. Moll R. Molecular diversity of eytokeratins: significance for cell and tumor differentiation. Acta Histochetnica-Suppl 1991: 41: 117-27
16. Moll R. Lo\ve A. Laufer J, Franke WW. Cytokeratin 20 in human carcinomas. A new histodiagnostic marker detected by monoclonal antibodies. Amer J Piithol 1992: 140:427-47
17. Harnden P. Allam A, Joyce AD, Patel A. Selby P. Southgate J. Cytokeratin 20 expression by non-invasive transitional cell carcinomas: potential for distinguishing recurrent from non-recurrent disease. Histopatlwlociu 1995: 27: 167-74
18. Moll R. Zimbelmann R, Goldschmidt MD et al. The human gene encoding cylokeratin 20 and its expression during fetal development and in gastrointestinal carcinomas. Differentiation 1993: 53: 75-93
19. Miettinen M. Keratin 20: immunohistochemical marker for gastrointestinal, urothelial and Merkel cell carcinomas. Mod Patliol 1995: 8: 3S4-8
20. Parenti A. Capitanio G. De Caro R. Dalla Palma P. Scanning electron microscopy of 'normal' urothelium in patients with infiltrating bladder carcinoma. Appl Pathol 1989: 7: 338-43
21. Hofstadter F. Delgado R. Jakse G. Judmaier W. Urothelial dysplasia and carcinoma in situ of the bladder. Cancer 1986: 57: 356-61
22. Hamano K, Kinjo M. Kumazawa J . Flow-cylometric deoxyribonucleic acid analysis of the human bladder cancers with reference to histopathological findings. Eur Urol 1992: 22: 15 3-7
23. Norming ['. Nyman CR. Trihukait B. Comparative histopathology and deoxyrihonucleic acid How cytometry of random mucosal biopsies in untreated bladder carcinoma. J Urol 1991: 145: 1164-8
24. Smith AF. An ultraslructural and morphometric study of bladder tumours (III). Virch Archiv-,4. I'athol Anal Histaimllwl 1985; 406: 7-16
25. Sanchez-Fernandez de Sevilla MC. Morell-Ouadrcny L. GilSalom M. Perez-Bacete M. Llombart-Bosch A. Morphometric and immunohistochemical characterization of bladder carcinoma in situ and its preneoplastic lesions. Eur Urol 1992: 21 (Suppl 1): 5-9
26. Helpap B. Vogel J. Oehr P. Adolphs HD. Comparison between cell kinetical and immunohistochemical studies on carcinoma and atypia/dysplasia of urinary bladder mucosa. Virch Archiv - A. Pathol Auat Histopalhol 1985: 406: 509-22